Bitget App
Trade smarter
Buy cryptoMarketsTradeFuturesStocksEarnInstitutionAI & More
Opinion: Mainstream coins may move sideways, Meme coins are expected to rise

Opinion: Mainstream coins may move sideways, Meme coins are expected to rise

Bitget2024/05/28 07:15

According to Shenzhen TechFlow, crypto trader Ansem said that mainstream coins may continue to trade sideways, while Meme coins are expected to rise. Ansem mentioned that Ethereum ($ETH) currently has a clear hedging short strategy, and if the price breaks $4100 on a weekly basis, the market may rise significantly. Otherwise, the market is expected to continue to fluctuate, forcing bulls to close their positions and leave.

0
0

Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.

Understand the market, then trade.
Bitget offers one-stop trading for cryptocurrencies, stocks, and gold.
Trade now!

You may also like

$40 billion in bond issuance with a maximum interest rate of 8.3%! SpaceX (SPCX.US) AI gamble also exposes the “funding winter” for AI infrastructure

According to media reports citing sources familiar with the matter, SpaceX is preparing to complete a debt issuance totaling $40 billion, with an interest rate significantly higher than previous borrowing costs, reflecting growing investor concerns over financing for artificial intelligence (AI) infrastructure.

智通财经•2026/10/23 01:02
$40 billion in bond issuance with a maximum interest rate of 8.3%! SpaceX (SPCX.US) AI gamble also exposes the “funding winter” for AI infrastructure

TS Lombard scenario analysis: An AI bubble burst could trigger a 30% plunge in the S&P 500, wiping out 20 trillion dollars in market value—but don't rush to short!

Dario Perkins from TS Lombard predicted in a scenario analysis released on Thursday that if AI capital expenditure collapses, approximately $20 trillions in U.S. stock market value could evaporate, triggering credit losses of $125 billions to $190 billions.

智通财经•2026/10/23 00:56

Gilead Sciences (GILD.US) acquires PepStar’s oral inflammation drug program for $1.275 billion in cash, increasing investment in inflammatory bowel disease pipeline

Gilead Sciences will acquire PepStar’s anti-inflammatory drug program for $1.28 billions.

智通财经•2026/10/23 00:37